# Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.

> **NCT02620384** · PHASE3 · TERMINATED · sponsor: **Aultman Health Foundation** · enrollment: 147 (actual)

## Conditions studied

- Acute Decompensated Heart Failure

## Interventions

- **DRUG:** Experimental: Placebo
- **DRUG:** Experimental: Metolazone

## Key facts

- **NCT ID:** NCT02620384
- **Lead sponsor:** Aultman Health Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10-01
- **Primary completion:** 2017-11-29
- **Final completion:** 2017-12-29
- **Target enrollment:** 147 (ACTUAL)
- **Why stopped:** Limited resources available to met accrual goal.
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02620384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02620384, "Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02620384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*